Partner with Intertek at BIO-EUROPE Spring

During BIO-EUROPE Spring, connect with Intertek through one-to-one partnering to explore how we can help you to achieve your biopharmaceutical development goals.

With a focus on innovation and global collaboration, our experts will be attending BIO-Europe Spring, March 12–14, 2018, Amsterdam, to discuss how our expertise can help you meet your development program milestones. Contact us now to arrange a meeting during BIO-EUROPE Spring or visit exhibition stand 65B.

Our protein characterisation services are developed in accordance with the ICH Q6B Guidance to ensure the quality, purity, potency and consistency of your biologic. Protein structure analysis, physiochemical property determination, biological and potency assays, product-and process-related impurity testing, are delivered from our team located in Manchester, UK. Our capabilities are focused on support for your product development, in-process testing, identity confirmation, comparability, stability testing and batch release testing. We are experienced in developing and validating assays for bioanalytical pharmacokinetic (PK), toxicokinetic (TK), immunogenicity, and biomarker studies supporting early discovery through to late stage clinical studies.

Our extensive experience in inhaled product development including all types of dry powder formulations and devices, nebulized solutions / suspensions and metered dose inhalation (pMDI) product types, as well as a range of other novel respiratory delivery systems. We have been working in the inhaled and nasal fields for over 25 years and have the necessary experience to help design, implement and support development with support through stability and testing services that are designed to provide the right information at the right time.


BROCHURE DOWNLOAD: Biopharmaceutical Services

BROCHURE DOWNLOAD: Inhalation Development and Testing Services

WHITE PAPER: Formulation of Biologics for inhaled and Nasal Delivery

WHITE PAPER: The Complexities of Antibody Drug Conjugate Characterisation

WHITE PAPER: Bioanalytical Determination of Pegylated Species by NMR


Bringing quality and safety to life, we offer Total Quality Assurance expertise to help you to meet and exceed quality, safety and regulatory standards for biotech innovation. Our thought-leaders have over 20 years’ experience in biopharmaceutical development support across a wide range of product types including proteins, monoclonal antibodies, vaccines, PEGylated proteins, antibody drug conjugates, peptides, cytokines (e.g., interferons), oligonucleotides, glycoproteins and biosimilars. With broad capabilities in Europe and North America we help you meet and exceed your quality, safety and efficacy requirements. Our experts provide strong scientific and technical leadership coupled with project management and regulatory support, to drive your development programs forward. 

Need help or have a question? +1-858-558-2599

Need help or have a question?

+44 161 721 5247